AI-Enabled Drug Discovery Cooperation

AstraZeneca and BenevolentAI Completes Third Milestone in Their AI-Enabled Drug Discovery Cooperation

AstraZeneca has identified an additional novel target for its drug development portfolio for idiopathic pulmonary fibrosis (IPF), allowing BenevolentAI, a…